A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF‐I without significant deterioration in glucose tolerance

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinical Endocrinology

• Publication date

  1999-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2265.1999.00595.xPMID 10341855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Diagnosis of Growth Hormone Deficiency in Adults

  1997cited by this paper
• Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.

  1997cited by this paper
• Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

  1997cited by this paper
• Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.

  1997cited by this paper
• Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women.

  1997cited by this paper
• Increased cerebrovascular mortality in patients with hypopituitarism

  1997cited by this paper
• The safety profile of GH replacement therapy in adults

  1997cited by this paper
• New approach to the diagnosis of growth hormone deficiency in adults.

  1996cited by this paper
• Diagnosis of growth hormone deficiency in adults.

  1996cited by this paper
• The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.

  1996cited by this paper
• Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.

  1996cited by this paper
• Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.

  1996cited by this paper
• The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.

  1995influential reference
• Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo.

  1995cited by this paper
• Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.

  1995cited by this paper
• The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis.

  1995cited by this paper
• The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

  1995cited by this paper
• Growth hormone-deficient adults are insulin-resistant.

  1995cited by this paper
• Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.

  1995cited by this paper
• Diagnosis of growth hormone deficiency in adults.

  1994cited by this paper
• Insulin Resistance, Body Fat Distribution, and Sex Hormones in Men

  1994cited by this paper
• Diagnosis of growth hormone deficiency in adults.

  1994cited by this paper
• Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency

  1994cited by this paper
• Circulating binding proteins for the insulinlike growth factors.

  1993cited by this paper
• Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.

  1993cited by this paper
• Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters

  1993influential reference
• Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

  1993cited by this paper
• The regulation of insulin‐like growth factor binding protein (IGFBP)‐1 during prolonged fasting

  1993cited by this paper
• Radioimmunoassay and related techniques.

  1993cited by this paper
• Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.

  1992cited by this paper
• Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study

  1992cited by this paper
• Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism.

  1992cited by this paper
• The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

  1992cited by this paper
• Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis.

  1992cited by this paper
• HemoCue: evaluation of a portable photometric system for determining glucose in whole blood.

  1992cited by this paper
• Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

  1991cited by this paper
• The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment.

  1991cited by this paper
• Insulin‐Like Growth Factor (IGF) Binding Proteins: the Role of Serum IGFBPs in Regulating IGF Availability

  1991cited by this paper
• Premature mortality due to cardiovascular disease in hypopituitarism.

  1990cited by this paper
• The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.

  1989cited by this paper
• Beneficial effects of growth hormone treatment in GH-deficient adults.

  1989cited by this paper
• Quality of Life Assessment Before and After Growth Hormone Treatment in Adults with Growth Hormone Deficiency

  1989cited by this paper
• Adiposity, fat distribution, and cardiovascular risk.

  1989influential reference
• Menstrual cyclicity has a profound effect on glucose homeostasis.

  1989cited by this paper
• ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?

  1988cited by this paper
• Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

  1988cited by this paper
• Diabetes mellitus. Report of a WHO Study Group.

  1985cited by this paper
• Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid.

  1984cited by this paper
• Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women.

  1983cited by this paper
• Treatment of male hypogonadism with testosterone enanthate.

  1980cited by this paper
• Reproducibility and Comparative Analysis of Repeated Intravenous and Oral Glucose Tolerance Tests

  1978cited by this paper
• The Assessment of Insulin, Glucose and Lipids in Ischemic Thrombotic Cerebrovascular Disease

  1975cited by this paper
• Serum-insulin in essential hypertension and in peripheral vascular disease.

  1966cited by this paper
• Hormone-fuel interrelationships during fasting.

  1966cited by this paper
• Reproducibility of the Oral Glucose Tolerance Test

  1965cited by this paper
• PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION.

  1965cited by this paper
• POWER-OPERATED PROSTHESES.

  1964cited by this paper

• Impact of Long-Term Growth Hormone Replacement Therapy on Metabolic and Cardiovascular Parameters in Adult Growth Hormone Deficiency: Comparison Between Adult and Elderly Patients

  2021cites this paper
• Effects of Growth Hormone (GH) Therapy Withdrawal on Glucose Metabolism in Not Confirmed GH Deficient Adolescents at Final Height

  2014cites this paper
• Diabetes in Growth Hormone Deficiency

  2014cites this paper
• Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: growth hormone deficiency.

  2014cites this paper
• Quality of life in transition phase in adolescents and young adults with severe and partial growth hormone deficiency.

  2014cites this paper
• Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions A Scientific Statement From the American Heart Association

  2013cites this paper
• and Research Directions: A Scientific Statement From the American Heart Association Prevention, Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who

  2013cites this paper
• Pituitary disease mortality: is it fiction?

  2013cites this paper
• Comparison of two dose regimens of growth hormone (GH) with different target IGF-1 levels on glucose metabolism, lipid profile, cardiovascular function and anthropometric parameters in gh-deficient adults.

  2012cites this paper
• Long-term effects of growth hormone replacement in hypopituitary adults on body composition, bone mass and cardiovascular risk factors

  2012cites this paper
• Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study

  2010cites this paper
• Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.

  2009cites this paper
• Safety aspects of GH replacement.

  2009cites this paper
• Effects of one-year low-dose growth hormone (GH) therapy on body composition, lipid profile and carbohydrate metabolism in young adults with childhood-onset severe GH deficiency confirmed after completion of growth promotion.

  2008cites this paper
• Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.

  2008cites this paper
• Management of growth hormone deficiency in adults.

  2007cites this paper
• Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes.

  2006cites this paper
• Glucose Metabolism and Visceral Fat in GH Deficient Adults: Two Years of GH-Replacement

  2005cites this paper
• Childhood malignant disease and consequences for growth hormone secretion, intellectual function and cardiovascular risk

  2005cites this paper
• : Growth Hormone and Cardiovascular Risk Factors

  2005cites this paper
• Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

  2005cites this paper
• Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults.

  2005influential citation
• Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.

  2004cites this paper
• Safety of growth hormone replacement therapy in adults

  2004cites this paper
• Survivors of childhood acute lymphoblastic leukaemia, with radiation‐induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment

  2004cites this paper
• Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement.

  2004cites this paper
• Effects of GH replacement on metabolism and physical performance in GH deficient adults

  2003cites this paper
• Long-Term Efficacy and Safety of Somatropin for Adult Growth Hormone Deficiency

  2003cites this paper
• Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD)

  2003cites this paper
• Absence of effects of long-term growth hormone replacement therapy on insulin sensitivity in adults with growth hormone deficiency of childhood-onset (GHDA-CO).

  2003cites this paper
• Growth hormone replacement therapy and insulin sensitivity.

  2003cites this paper
• Central effects of the somatotropic system.

  2003cites this paper
• A dose titration model for recombinant GH substitution aiming at normal plasma concentrations of IGF-I in hypopituitary adults.

  2002cites this paper
• Individualizing Growth Hormone Dosing in Children

  2002cites this paper
• Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation.

  2002cites this paper
• Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety.

  2002cites this paper
• Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.

  2002cites this paper
• The importance of growth hormone (GH) and GH secretagogues for bone mass and density.

  2002cites this paper
• Hypopituitarism and Growth Hormone Deficiency

  2002cites this paper
• Low individualized growth hormone (GH) dose increased renal and cardiac growth in young adults with childhood onset GH deficiency

  2001cites this paper
• Expression of insulin target genes in skeletal muscle and adipose tissue in adult patients with growth hormone deficiency: effect of one year recombinant human growth hormone therapy.

  2001cites this paper
• [The syndrome of growth hormone deficiency in adults: current criteria for the diagnosis and treatment].

  2000cites this paper
• Monitoring serum insulin‐like growth factor‐I (IGF‐I), IGF binding protein‐3 (IGFBP‐3), IGF‐I/IGFBP‐3 molar ratio and leptin during growth hormone treatment for disordered growth

  2000cites this paper
• El síndrome de deficiencia de hormona del crecimiento en adultos: criterios actuales para el diagnóstico y tratamiento

  2000cites this paper
• A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners

  2000cites this paper
• Individualized low-dose growth hormone (GH) treatment in GH-deficient adults with childhood-onset disease: metabolic effects during fasting and hypoglycemia.

  1999cites this paper